Amgen ends partnership with AstraZeneca on psoriasis drug

May 23, 2015 1:20 PM

79 2

REUTERS: Amgen Inc said it will terminate a collaboration with AstraZeneca Plc to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial.

Amgen said such safety concerns would likely result in a restrictive label that could limit the number of patients using the late-stage experimental drug, brodalumab.

Read more

To category page